ALFA FinderBSE filing, NSE: TTFL. Summary written from the filing by ALFA Finder's alert engine.
Trident Texofab Ltd: key numbers
- Share price
- ₹22.57
- Market cap
- ₹33.85 Cr
- Revenue (annual)
- ₹118.0 Cr
- Net profit (annual)
- ₹0.70 Cr
- P/E (TTM)
- -108.0×Sector 48.2×
- Promoter holding
- 32.88%+0.72% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Trident Texofab Ltd
All →Trident Texofab Q2 FY27 Results: Net Profit ₹0.6 Cr, Down 45.5% YoY
Trident Texofab approved unaudited standalone results for the quarter ended September 2026. Quarterly revenue fell to ₹2,533.77 lakh from ₹3,063.46 lakh a year earlier.
- Key figure
- Net profit ₹0.6 Cr · -45.5% YoY
Trident Texofab Board Meeting Date
Trident Texofab schedules a board meeting on 5 November 2026 to consider unaudited quarterly results. No financial figures are disclosed yet.
Trident Texofab Annual General Meeting
Trident Texofab's EGM on 28 October 2026 sought approval for a statutory auditor to fill a casual vacancy. Only one ordinary resolution was tabled.
Trident Texofab Other Announcement
Trident Texofab Ltd has submitted its quarterly shareholding pattern filing for the period ending September 30, 2026, as per regulatory requirements.
Trident Texofab Management Change
Trident Texofab Limited has appointed M/s. A Bafna & Associates as the new Statutory Auditor for a term of 12 months.
Trident Texofab Board Meeting Outcome
Trident Texofab Ltd's board approved the appointment of a statutory auditor to fill a casual vacancy and convened an EGM for October 28, 2026.
Other other announcement announcements
All →Neueon Corporation Other Announcement
Neueon Corporation's members approved amendments to its Articles of Association via postal ballot, now approved by the Registrar of Companies. The amendment allows the Board to make multiple calls on partly paid shares.
Balaxi Pharmaceuticals Other Announcement
Balaxi Pharmaceuticals filed its RTA report for October 2026 on re-lodgement of physical share transfers. All request counts for the month are NIL.
Leapfrog Engineering Services Other Announcement
Leapfrog Engineering received a Trade Mark registration certificate for building construction services in Class 37. The registration discloses no monetary value or business impact.
Quest Laboratories Other Announcement
Quest Laboratories reported no deviation in IPO fund utilisation for the half year ended September 2026. Its statement was reviewed by the Audit Committee.
Vinyas Innovative Technologies Other Announcement
Vinyas Innovative filed CRISIL's monitoring agency report for the quarter ended 30 September 2026. It reports no deviation from objects for its preferential warrant issue proceeds.
Parag Milk Foods Other Announcement
Sixth Sense India Opportunities III sold 43,842 shares on NSE for about Rs 1.45 Crore. Its stake fell from 1.44% to 1.40%.
- Value
- ₹1.45 Cr